Riskpilot← Back to searchSign inGet full accessMehbod Mansoori AB
ABActiveOrg 5591059489Byvägen 36General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 281K
-8% vs 2023
EBITDA margin
-15.3%
-258% vs 2023
Equity ratio
73.6%
Financial strength
Net profit 2024
SEK -53K
-121% vs 2023
| Revenue | SEK 281K | -8% |
| EBITDA | SEK -43K | -258% |
| Net profit | SEK -53K | -121% |
| Total assets | SEK 397K | -9% |
| Equity | SEK 292K | -15% |
| Employees | 0 | — |
Legal name
Mehbod Mansoori AB
Org number
5591059489
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 mars 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsultverksamhet inom hälso- och sjukvård, både digitalt och fysiskt, inom både primärvård och specialistvård, samt kosmetisk estetik. Uthyrning av sjukvårdspersonal samt därmed förenlig verksamhet. Äga och förvalta fastigheter, bostäder, värdepapper, fordon och lös egendom samt därmed förenlig verksamhet.
Address
Byvägen 36
Email
mehbod.mansoori@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 369 | 479 | 237 | 305 | 281 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 74 | 160 | −36 | −12 | −43 |
| Depreciation & amort. | −7 | −13 | −13 | −13 | −12 |
| EBIT | 67 | 147 | −49 | −25 | −55 |
| Net financials | — | — | — | 1 | 2 |
| Profit before tax | 67 | 146 | −49 | −24 | −53 |
| Tax | −14 | −30 | −0 | −0 | −0 |
| Net profit | 53 | 116 | −49 | −24 | −53 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 608 | 694 | 398 | 436 | 397 |
| Equity | 427 | 544 | 370 | 345 | 292 |
| Long-term debt | 67 | 29 | 4 | 36 | 68 |
| Short-term debt | 114 | 121 | 24 | 54 | 36 |
| Total debt | 181 | 150 | 28 | 90 | 104 |
EBITDA margin
-15.3%
This company
15.8%
Market median
-197% vs market
20202024
Equity ratio
73.6%
This company
38.2%
Market median
+93% vs market
20202024
Return on equity
-18.2%
This company
18.4%
Market median
-199% vs market
20202024
Net profit margin
-18.9%
This company
8.1%
Market median
-333% vs market
20202024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20202024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mehbod Mansoori AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mehbod Mansoori | Chief Executive Officer | 0 companies |
| Ariobarzan Mansoori | Deputy Board Member | 0 companies |